Spinraza Plus Zolgensma Offers Little Extra Benefit in Type 1, Study Suggests

Jan 31, 2022, 12:00 AM

SMA News Today’s multimedia associate, Price Wooldridge, reads an article about how a small group of children given the gene therapy after Spinraza's start showed only slight further gains; early treatment most important.
Also, in her latest vlog DeAnn Runge explores the topic of furry friends. Pets are an important aspect of her life. She explains how she feels pets can benefit the lives of anyone living with SMA.
Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/.